Saturday, October 31, 2026

FuboTV Stock Over 15% Down So Far On Monday

FuboTV Stock Over 15% Down So Far On Monday

FuboTV (NYSE: FUBO), a live TV streaming platform, experienced its third consecutive day of losses on Monday, marking the latest episode in its demonstrated volatility.

FuboTV's Earnings

Earnings per share (EPS) for FuboTV over the past year stand at 1.95, and growth estimates for the current and upcoming quarters are projected at 52.4% and 56.1% respectively. This data hints at a mismatch between the company's potential for expansion and the present state of its stock prices.

Stock Performance

Contrary to the positive trend in Monday's New York Stock Exchange sessions, FuboTV stock took a hit as share prices fell by 0.65%. This is yet another example of the streaming platform's fluctuating market performance.

Volatility

Over the past week, FuboTV experienced an average intraday variation of -1.64%. However, the stock did see positive averages overall in each of its three most recent periods: month, and quarter respectively. Its highest volatility reached 2.27% last week, 6.82% during the first month, and 6.10% during the third quarter, reinforcing the idea that investors have a roller coaster ride with this stock.

Investment Considerations

It's crucial for investors to keep this volatility in mind when considering future actions with FuboTV's stock. Even though the share price has suffered and volatility has surged, projections still forecast positive growth for the company. Sound investment decisions should take into account a combination of factors, including stock performance, company growth, market trends, and economic indicators.

More news about FuboTV (FUBO).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com